Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8

1.

Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment.

Hassett MJ, Schymura MJ, Chen K, Boscoe FP, Gesten FC, Schrag D.

Cancer. 2016 Feb 1;122(3):420-31. doi: 10.1002/cncr.29777. Epub 2015 Nov 4.

PMID:
26536043
2.

Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference.

Landercasper J, Attai D, Atisha D, Beitsch P, Bosserman L, Boughey J, Carter J, Edge S, Feldman S, Froman J, Greenberg C, Kaufman C, Morrow M, Pockaj B, Silverstein M, Solin L, Staley A, Vicini F, Wilke L, Yang W, Cody H 3rd.

Ann Surg Oncol. 2015 Oct;22(10):3174-83. doi: 10.1245/s10434-015-4759-x. Epub 2015 Jul 28.

3.

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E.

Ann Oncol. 2014 Oct;25(10):1871-88. doi: 10.1093/annonc/mdu385. Epub 2014 Sep 18. No abstract available.

4.

Evidence-informed recommendations for constructing and disseminating messages supplementing the new Canadian Physical Activity Guidelines.

Latimer-Cheung AE, Rhodes RE, Kho ME, Tomasone JR, Gainforth HL, Kowalski K, Nasuti G, Perrier MJ, Duggan M; Canadian Physical Activity Guidelines Messaging Recommendation Workgroup.

BMC Public Health. 2013 May 1;13:419. doi: 10.1186/1471-2458-13-419.

5.

A simulation model approach to analysis of the business case for eliminating health care disparities.

Nerenz DR, Liu YW, Williams KL, Tunceli K, Zeng H.

BMC Med Res Methodol. 2011 Mar 19;11:31. doi: 10.1186/1471-2288-11-31.

6.

Lessons learned in the development of process quality indicators for cancer care in Japan.

Higashi T.

Biopsychosoc Med. 2010 Nov 5;4:14. doi: 10.1186/1751-0759-4-14.

7.

Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.

Wilke LG, Ballman KV, McCall LM, Giuliano AE, Whitworth PW, Blumencranz PW, Reintgen DS, Burak WE, Leitch AM, Hunt KK.

Ann Surg Oncol. 2010 Aug;17(8):1989-94. doi: 10.1245/s10434-010-0980-9. Epub 2010 Mar 23.

8.

Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.

Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC.

J Clin Oncol. 2008 Dec 1;26(34):5553-60. doi: 10.1200/JCO.2008.17.9705. Epub 2008 Oct 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk